Therapeutic approaches to hemoglobin switching in treatment of hemoglobinopathies.
about
Isolation of a differentially regulated splicing isoform of human NF-E2Induction of fetal hemoglobin by propionic and butyric acid derivatives: correlations between chemical structure and potency of Hb F inductionFuture prospects for treatment of hemoglobinopathies.Design of embedded chimeric peptide nucleic acids that efficiently enter and accurately reactivate gene expression in vivoCompound loss of function of nuclear receptors Tr2 and Tr4 leads to induction of murine embryonic β-type globin genesGlobin gene transfer for the treatment of severe hemoglobinopathies: a paradigm for stem cell-based gene therapy.Sustained induction of fetal hemoglobin by pulse butyrate therapy in sickle cell disease.Short-chain fatty acid derivatives induce fetal globin expression and erythropoiesis in vivo.Pharmacological induction of fetal hemoglobin synthesis using histone deacetylase inhibitors.Role of the duplicated CCAAT box region in gamma-globin gene regulation and hereditary persistence of fetal haemoglobinThe role of methyltransferase inhibitors in the management of the myelodysplastic syndromes.Acetylation and modulation of erythroid Krüppel-like factor (EKLF) activity by interaction with histone acetyltransferases.HIV, but not murine leukemia virus, vectors mediate high efficiency gene transfer into freshly isolated G0/G1 human hematopoietic stem cells.Methylation-enhanced binding of Sp1 to the stage selector element of the human gamma-globin gene promoter may regulate development specificity of expression.Milestones in the history of hemoglobin research (in memory of professor Titus H.J. Huisman).Heterochromatin Protein 1γ Is a Novel Epigenetic Repressor of Human Embryonic ϵ-Globin Gene Expression.Hydroxyurea in Sickle Cell Disease: Our Experience in Western India.Site-specific acetylation by p300 or CREB binding protein regulates erythroid Krüppel-like factor transcriptional activity via its interaction with the SWI-SNF complex.Potential Hemoglobin A/F role in clinical Malaria.ε-globin expression is regulated by SUV4-20h1.Understanding fetal globin gene expression: a step towards effective HbF reactivation in haemoglobinopathies.Cellular and molecular effects of a pulse butyrate regimen and new inducers of globin gene expression and hematopoiesis.
P2860
Q24564535-25A21ADE-C086-4D2D-A9E3-53F98F572C14Q33598612-F54BC4E3-142F-4720-851A-73849845D972Q33606876-E05A5976-7323-4B1F-9FE8-5FF20DE9B55AQ34165634-49F4B1D6-FD51-4A59-99EB-8B53A499F7B5Q34456733-FA26ACC2-AA28-41D5-8D9E-38DC67D467BDQ34587615-A1A5DF04-5BBE-4B60-BDC5-19DD186973EEQ34723434-EF17B653-E082-4C16-B6BF-BF6CD671318AQ34723868-7C212DD9-4F35-4F90-AE1F-237EFEE5C220Q35809469-B89A54B4-2BA0-4D23-AF84-2CEA1271788FQ35842784-72223546-901B-4B6E-AB4B-661D3181D11EQ35996501-66EB0099-37C5-47FF-AEC7-3BEF8C3DEDD1Q36278311-2A01D1A9-65A5-425B-ADA0-08C7E357D721Q36326611-DB6EBB50-4F81-4224-B664-6CD3E5F8F4F4Q36685090-342F4039-1DC2-47A5-B866-0F925F526C9FQ37935768-03DE3ADB-0D58-4701-87C7-77A82FE631F6Q38718204-8B8D42DA-C511-4D86-B26F-DCE82E889970Q38955195-C1FA59D4-E072-41E4-B34F-D8FB80688A0AQ39458728-4665984E-E8B3-45AE-8F2C-3BF3B87E105DQ41670231-F5888419-7C11-4BB1-92C1-A8832E945398Q42399874-2C08A306-E138-4C11-BB2B-1999755BC5ACQ47720716-CE93CBFD-11C0-46AC-8417-C18CB4C28F45Q47824736-3B43925F-061C-4E80-A830-96603AA489FC
P2860
Therapeutic approaches to hemoglobin switching in treatment of hemoglobinopathies.
description
1992 nî lūn-bûn
@nan
1992 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
1992 թվականի հունվարին հրատարակված գիտական հոդված
@hy
1992年の論文
@ja
1992年論文
@yue
1992年論文
@zh-hant
1992年論文
@zh-hk
1992年論文
@zh-mo
1992年論文
@zh-tw
1992年论文
@wuu
name
Therapeutic approaches to hemoglobin switching in treatment of hemoglobinopathies.
@ast
Therapeutic approaches to hemoglobin switching in treatment of hemoglobinopathies.
@en
type
label
Therapeutic approaches to hemoglobin switching in treatment of hemoglobinopathies.
@ast
Therapeutic approaches to hemoglobin switching in treatment of hemoglobinopathies.
@en
prefLabel
Therapeutic approaches to hemoglobin switching in treatment of hemoglobinopathies.
@ast
Therapeutic approaches to hemoglobin switching in treatment of hemoglobinopathies.
@en
P1476
Therapeutic approaches to hemoglobin switching in treatment of hemoglobinopathies.
@en
P2093
Nienhuis AW
Stamatoyannopoulos JA
P304
P356
10.1146/ANNUREV.ME.43.020192.002433
P577
1992-01-01T00:00:00Z